Matches in SemOpenAlex for { <https://semopenalex.org/work/W3006984773> ?p ?o ?g. }
- W3006984773 abstract "Abstract Background There has been a successful push towards parasitological diagnosis of malaria in Africa, mainly with rapid diagnostic tests (mRDTs), which has reduced over-prescribing of artemisinin-based combination therapies (ACT) to malaria test-negative patients. The effect on prescribing for test-positive patients has received much less attention. Malaria infection in endemic Africa is often most dangerous for young children and those in low-transmission settings. This study examined non-prescription of antimalarials for patients with malaria infection demonstrated by positive mRDT results, and in particular these groups who are most vulnerable to poor outcomes if antimalarials are not given. Methods Analysis of data from 562,762 patients in 8 studies co-designed as part of the ACT Consortium, conducted 2007–2013 in children and adults, in Cameroon, Ghana, Nigeria, Tanzania, and Uganda, in a variety of public and private health care sector settings, and across a range of malaria endemic zones. Results Of 106,039 patients with positive mRDT results (median age 6 years), 7426 (7.0%) were not prescribed an ACT antimalarial. The proportion of mRDT-positive patients not prescribed ACT ranged across sites from 1.3 to 37.1%. For patients under age 5 years, 3473/44,539 (7.8%) were not prescribed an ACT, compared with 3833/60,043 (6.4%) of those aged ≥ 5 years. The proportion of < 5-year-olds not prescribed ACT ranged up to 41.8% across sites. The odds of not being prescribed an ACT were 2–32 times higher for patients in settings with lower-transmission intensity (using test positivity as a proxy) compared to areas of higher transmission. mRDT-positive children in low-transmission settings were especially likely not to be prescribed ACT, with proportions untreated up to 70%. Of the 7426 mRDT-positive patients not prescribed an ACT, 4121 (55.5%) were prescribed other, non-recommended non-ACT antimalarial medications, and the remainder (44.5%) were prescribed no antimalarial. Conclusions In eight studies of mRDT implementation in five African countries, substantial proportions of patients testing mRDT-positive were not prescribed an ACT antimalarial, and many were not prescribed an antimalarial at all. Patients most vulnerable to serious outcomes, children < 5 years and those in low-transmission settings, were most likely to not be prescribed antimalarials, and young children in low-transmission settings were least likely to be treated for malaria. This major public health risk must be addressed in training and practice. Trial registration Reported in individual primary studies." @default.
- W3006984773 created "2020-03-06" @default.
- W3006984773 creator A5012805826 @default.
- W3006984773 creator A5017826297 @default.
- W3006984773 creator A5023047768 @default.
- W3006984773 creator A5026823453 @default.
- W3006984773 creator A5029384863 @default.
- W3006984773 creator A5036366931 @default.
- W3006984773 creator A5040567688 @default.
- W3006984773 creator A5053257110 @default.
- W3006984773 creator A5056093448 @default.
- W3006984773 creator A5071038273 @default.
- W3006984773 creator A5081120679 @default.
- W3006984773 creator A5084793313 @default.
- W3006984773 creator A5086867664 @default.
- W3006984773 creator A5087455123 @default.
- W3006984773 date "2020-01-30" @default.
- W3006984773 modified "2023-10-17" @default.
- W3006984773 title "Patients with positive malaria tests not given artemisinin-based combination therapies: a research synthesis describing under-prescription of antimalarial medicines in Africa" @default.
- W3006984773 cites W1531989075 @default.
- W3006984773 cites W1552087785 @default.
- W3006984773 cites W1648137791 @default.
- W3006984773 cites W1970787992 @default.
- W3006984773 cites W1977232468 @default.
- W3006984773 cites W1977731028 @default.
- W3006984773 cites W2038626270 @default.
- W3006984773 cites W2052618566 @default.
- W3006984773 cites W2057204208 @default.
- W3006984773 cites W2065151287 @default.
- W3006984773 cites W2081118413 @default.
- W3006984773 cites W2082929650 @default.
- W3006984773 cites W2091649381 @default.
- W3006984773 cites W2105842235 @default.
- W3006984773 cites W2109967797 @default.
- W3006984773 cites W2112365949 @default.
- W3006984773 cites W2115254384 @default.
- W3006984773 cites W2124850308 @default.
- W3006984773 cites W2134315162 @default.
- W3006984773 cites W2135626723 @default.
- W3006984773 cites W2138298900 @default.
- W3006984773 cites W2140654386 @default.
- W3006984773 cites W2146465645 @default.
- W3006984773 cites W2146597493 @default.
- W3006984773 cites W2147671759 @default.
- W3006984773 cites W2149590825 @default.
- W3006984773 cites W2151965230 @default.
- W3006984773 cites W2152499611 @default.
- W3006984773 cites W2158011093 @default.
- W3006984773 cites W2158958915 @default.
- W3006984773 cites W2158997131 @default.
- W3006984773 cites W2189264859 @default.
- W3006984773 cites W2253215756 @default.
- W3006984773 cites W2462858202 @default.
- W3006984773 cites W2513603694 @default.
- W3006984773 cites W2547017020 @default.
- W3006984773 cites W2563016760 @default.
- W3006984773 cites W2577639839 @default.
- W3006984773 cites W2580292717 @default.
- W3006984773 cites W2592154466 @default.
- W3006984773 cites W2592598035 @default.
- W3006984773 cites W2593102090 @default.
- W3006984773 cites W2595872067 @default.
- W3006984773 cites W2601964528 @default.
- W3006984773 cites W2615915024 @default.
- W3006984773 cites W2742398833 @default.
- W3006984773 cites W2885936885 @default.
- W3006984773 cites W2900762761 @default.
- W3006984773 cites W2977143779 @default.
- W3006984773 cites W2981619872 @default.
- W3006984773 doi "https://doi.org/10.1186/s12916-019-1483-6" @default.
- W3006984773 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6990477" @default.
- W3006984773 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/31996199" @default.
- W3006984773 hasPublicationYear "2020" @default.
- W3006984773 type Work @default.
- W3006984773 sameAs 3006984773 @default.
- W3006984773 citedByCount "13" @default.
- W3006984773 countsByYear W30069847732020 @default.
- W3006984773 countsByYear W30069847732021 @default.
- W3006984773 countsByYear W30069847732022 @default.
- W3006984773 countsByYear W30069847732023 @default.
- W3006984773 crossrefType "journal-article" @default.
- W3006984773 hasAuthorship W3006984773A5012805826 @default.
- W3006984773 hasAuthorship W3006984773A5017826297 @default.
- W3006984773 hasAuthorship W3006984773A5023047768 @default.
- W3006984773 hasAuthorship W3006984773A5026823453 @default.
- W3006984773 hasAuthorship W3006984773A5029384863 @default.
- W3006984773 hasAuthorship W3006984773A5036366931 @default.
- W3006984773 hasAuthorship W3006984773A5040567688 @default.
- W3006984773 hasAuthorship W3006984773A5053257110 @default.
- W3006984773 hasAuthorship W3006984773A5056093448 @default.
- W3006984773 hasAuthorship W3006984773A5071038273 @default.
- W3006984773 hasAuthorship W3006984773A5081120679 @default.
- W3006984773 hasAuthorship W3006984773A5084793313 @default.
- W3006984773 hasAuthorship W3006984773A5086867664 @default.
- W3006984773 hasAuthorship W3006984773A5087455123 @default.
- W3006984773 hasBestOaLocation W30069847731 @default.
- W3006984773 hasConcept C126322002 @default.
- W3006984773 hasConcept C138816342 @default.
- W3006984773 hasConcept C156957248 @default.
- W3006984773 hasConcept C159110408 @default.